Datelliptium chloride is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It is known for its potential anti-tumor properties, making it a subject of interest in the development of chemotherapeutic agents. Researchers explore its ability to inhibit the growth of cancer cells, focusing on its interaction with cellular mechanisms that regulate cell division and apoptosis. Additionally, it is investigated for its role in enhancing the efficacy of other cancer treatments when used in combination therapies. Its application extends to laboratory studies where it serves as a tool for understanding the molecular pathways involved in cancer progression and resistance to treatment.